Personalis, Inc. (XETR:04X) Financings
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Tranche closed: US$17.8M raised · US$5.89 a share | May 6, 2025 |
| Strategic investment of common stock Announced: US$50M · US$3.56 a share Buyers: Merck ($50 million of common stock; approximately 14 million shares, approximately 16.5 percent beneficial ownership following closing) | Dec 19, 2024 |